Glaucoma
📧 Sign up to get email alerts when something new happens for Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-08-24Clinical Trial Update: Persistence of Glaucoma Patients With Web-Browser-Based Visual Field Test [NA]
The clinical trial 'Persistence of Glaucoma Patients With Web-Browser-Based Visual Field Test' has been withdrawn; the study concerns glauco…
-
CLINICAL_TRIALS withdrawal · 2024-09-03Clinical Trial Update: Factors Affecting Aqueous Humor Outflow Facility in Patients with Uveitis
This clinical trial studied factors affecting aqueous humor outflow facility in patients with uveitis and glaucoma. The study has been withd…
-
CLINICAL_TRIALS withdrawal · 2024-08-21Clinical Trial Update: Use of Bevacizumab to Modulate the Outcomes of Trabeculectomy Surgery [Phase 4]
A Phase 4 trial evaluating bevacizumab to modulate outcomes of trabeculectomy surgery for glaucoma was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-08-21Clinical Trial Update: The Laser in Pseudoexfoliation (LIP) Study [Phase 4]
A Phase 4 clinical trial evaluating laser treatment for glaucoma (LIP study) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-20Clinical Trial Update: Effect of Negative Pressure on Pattern Electroretinography Readings [NA]
A clinical trial examining the effect of negative pressure on pattern electroretinography readings in glaucoma-related conditions has been w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2022-10-04Clinical Trial Update: Augmented Macular Pigment-containing Nutraceutical and Central Visual Function [Phase 4]
Phase 4 trial investigating augmented macular pigment nutraceutical for glaucoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-11-17Clinical Trial Update: PREFERENTIAL Study [Phase 2, Phase 3]
A clinical trial update shows the PREFERENTIAL study (Phase 2/3) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-02-02Clinical Trial Update: Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device [Phase 3]
Phase 3 trial evaluating safety and efficacy of Xalatan delivered by a conventional dropper bottle versus a delivery device was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-05-15Clinical Trial Update: The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients. [Phase 4]
Phase 4 trial investigating secondary benefits of a prostaglandin analog in Thyroid Eye Disease was withdrawn; the study also referenced ocu…
-
CLINICAL_TRIALS withdrawal · 2018-04-25Clinical Trial Update: Baerveldt Plate Area Comparison (BPAC) [NA]
The BPAC trial evaluating Baerveldt plate area for glaucoma has been terminated.
-
CLINICAL_TRIALS withdrawal · 2017-02-28Clinical Trial Update: Omega 3 Supplementation and Ocular Surface Disease in Glaucoma [NA]
The clinical trial investigating omega-3 supplementation for ocular surface disease in glaucoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-12-02Clinical Trial Update: Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population
A pediatric vision-screening trial evaluating a photoscreener in Haiti has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-11-21Clinical Trial Update: The Changes Within the Cells of the Drainage System of the Eye in Patients With Glaucoma [NA]
A glaucoma trial conducted by Wills Eye (NCT02524431) has been withdrawn, with no results reported.
-
CLINICAL_TRIALS withdrawal · 2016-05-13Clinical Trial Update: Intra-observer and Inter-observer Variability With Dynamic Contour Tonometry.
The clinical trial investigated intra- and inter-observer variability in dynamic contour tonometry for intraocular pressure measurements, bu…
-
CLINICAL_TRIALS withdrawal · 2015-09-23Clinical Trial Update: Effect of an Anterior Chamber Infusion System on Trabeculectomy Outcomes [Phase 1]
A Phase 1 clinical trial evaluating an anterior chamber infusion system to improve trabeculectomy outcomes for glaucoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-10Clinical Trial Update: Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Parkinson's Disease
The clinical trial evaluating the cellular proteome from leukocytes in glaucoma patients and in patients with Parkinson's disease has been w…
-
CLINICAL_TRIALS withdrawal · 2015-03-10Clinical Trial Update: Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Alzheimer's Disease
The clinical trial comparing cellular proteomes from leukocytes of glaucoma patients with those of Alzheimer's disease patients has been wit…
-
CLINICAL_TRIALS withdrawal · 2014-11-21Clinical Trial Update: Effects of Common Topical Glaucoma Therapy on Optic Nerve Head Blood Flow Autoregulation During Increased Arterial Blood Pressure and Artificially Elevated Intraocular Pressure in Healthy Humans [NA]
A clinical trial evaluating a common topical glaucoma therapy's effect on optic nerve head blood flow autoregulation during increased arteri…
-
CLINICAL_TRIALS withdrawal · 2014-11-21Clinical Trial Update: Effect of Rosuvastatin on Endothelial Function in Patients With Diabetes and Glaucoma [Phase 4]
This Phase 4 trial evaluating rosuvastatin's effect on endothelial function in patients with diabetes and glaucoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-09-17Clinical Trial Update: A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Phase 2]
A Phase 2 trial evaluating a latanoprost punctal plug delivery system for ocular hypertension or open-angle glaucoma was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-07-18Clinical Trial Update: Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of a triple combination dorzolamide hydrochloride/brimonidine tartrate/timolol ophthalmic…
-
CLINICAL_TRIALS withdrawal · 2013-02-07Clinical Trial Update: Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia [Phase 4]
A Phase 4 clinical trial evaluating DuoTrav as replacement therapy for glaucoma and ocular hypertension in Russia has been withdrawn.